Risultati di ricerca
Charterhouse Capital Partners is a London based private equity investment firm focused on investing in European mid-market companies valued between €200m and €1.5bn. The company targets investments across the services, healthcare, specialised industrials and consumer sectors.
Private Equity Executives each having over 30 years of experience managing and investing over $2 Billion of institutional equity in over 100 companies with numerous add-on investments. Decades of successful partnering with management and shareholders.
Charterhouse Capital Partners overview. Founded in 1934, Charterhouse Capital Partners is a private equity firm specialising in mid-market companies that invests in the services, healthcare, industrials and consumer sectors and buyout investments across Europe and the United States.
back to news Charterhouse Capital Partners-backed SERB to acquire BTG Specialty Pharmaceuticals. December 01, 2020. Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest established private equity firms operating in Europe, announces that its portfolio company Laboratoires SERB (“SERB”), a leading European specialty pharmaceutical group focused on prescription ...
18 dic 2020 · back to news Charterhouse Capital Partners announces investment in Vermeg. December 18, 2020. Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest established private equity firms operating in Europe, announces that it has made an investment in Vermeg (“the company”), a leading provider of software and digitalisation solutions for the financial services industry.
8 giu 2023 · 8 June 2023. Charterhouse Capital Partners, one of the UK’s oldest private equity firms, has closed its second continuation fund this year, attracting backing from Goldman Sachs Asset Management, CPP Investments and Hamilton Lane. The London-headquartered firm moved speciality pharmaceutical group SERB out of its 2016 Charterhouse Capital ...
back to news Charterhouse Capital Partners announces investment in PHASTAR. January 05, 2021. Charterhouse Capital Partners LLP (“Charterhouse”), one of the longest established private equity firms operating in Europe, announces that it has invested in PHASTAR (“the company”), a specialist provider of biostatistics and data science services for clinical trials.
